This is in contrast with a previous study showing that loss of AMPKα2 exaggerated pressure overload-induced cardiac remodeling indicating AMPK as a negative regulator of cardiac hypertrophy [44]. The gene discussed is PRKAA2; the disease is cardiac hypertrophy.